Enzalutamide can prolong survival in certain patients with prostate cancer, and delay occurrence of bone lesions. The new drug also offers advantages with regards to pain.
Enzalutamide can prolong survival in certain patients with prostate cancer, and delay occurrence of bone lesions. The new drug also offers advantages with regards to pain.